BIRC5 and cancer: Initially, survivin was described as an inhibitor of caspase-9 (32); however, several studies have shown that the role of survivin in cancer pathogenesis is not limited to the inhibition of apoptosis but also involves regulation of the mitotic spindle checkpoint, and promotion of angiogenesis and chemoresistance (28,33–36).